112489 ⎘
Preparation of compounds containing saccharide radicals; Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin Avermectin; Milbemycin; Ivermectin; C-076
Methods and compositions for recombinase-based genetic diversification
#2Recombinant microorganism expressing avermectin analogue and use thereof
#3Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
#4MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#5MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#6Dermatological compositions comprising avermectin nanocapsules
#7Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
#8Dermatological compositions comprising avermectin nanocapsules
#9gene directing the ratio of B2:B1 avermectins
#10Biocatalytic oxidation process useful in the manufacture of moxidectin
#11gene directing the ratio of B2:B1 avermectins
#12Avermectin aglycon synthase genes
#13Adenosylmethionine synthetase from , gene sequences coding the same and method for mass production of secondary metabolites including antibiotics thereof